×

Jury selection underway in Martin Shkreli securities trial

11:39 AM ET Mon, 26 June 2017

CNBC's Meg Tirrell reports the latest on the Martin Shkreli, the pharmaceuticals executive who gained public infamy by unapologetically hiking the price of a drug by more than 5,000 percent, fraud trial.